Embecta EMBC
NASDAQ EMBC
$5.59 +0.29 (+5.47%)
At close: Sep 22, 2026 · 4:00 PM EDT

Embecta (EMBC) Cash & Equivalents Growth (3y) (2025 - 2026)

Analysis

Embecta (EMBC) Cash & Equivalents Growth (3y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 178.18 Bn 173.23 Bn 7.27 Bn -13.31%
2 Intuitive Surgical 142.14 Bn 137.06 Bn 1.96 Bn -7.03%
3 Medtronic 117.43 Bn 109.23 Bn 6.34 Bn 8.09%
4 Stryker 105.15 Bn 101.68 Bn 4.50 Bn 34.27%
5 Boston Scientific 63.37 Bn 63.08 Bn 3.85 Bn 8.16%
6 Edwards Lifesciences 50.93 Bn 46.79 Bn 1.35 Bn 40.74%
7 Dexcom 33.65 Bn 31.71 Bn 830.00 Mn -2.57%
8 Resmed 32.27 Bn 30.80 Bn 861.22 Mn 86.12%
9 Alcon 31.62 Bn 30.17 Bn 1.68 Bn 27.03%
10 Embecta 300.30 Mn 82.10 Mn 153.30 Mn -12.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.22%
Mar 31, 2026 -18.88%
Dec 31, 2025 -19.45%
Sep 30, 2025 -12.00%
Jun 30, 2025 -7.60%
Mar 31, 2025 -7.48%
API Access

Embecta Cash & Equivalents Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-3y&ticker=EMBC&period=max&api_key=YOUR_API_KEY